MA41641A - Dérivés de tétrahydropyranylbenzamide - Google Patents
Dérivés de tétrahydropyranylbenzamideInfo
- Publication number
- MA41641A MA41641A MA041641A MA41641A MA41641A MA 41641 A MA41641 A MA 41641A MA 041641 A MA041641 A MA 041641A MA 41641 A MA41641 A MA 41641A MA 41641 A MA41641 A MA 41641A
- Authority
- MA
- Morocco
- Prior art keywords
- tetrahydropyranylbenzamide
- derivatives
- tetrahydropyranylbenzamide derivatives
- Prior art date
Links
- PYNBPZYZHMAOFS-UHFFFAOYSA-N O1C(CCCC1)C1=CC=CC=C1C(=O)N Chemical class O1C(CCCC1)C1=CC=CC=C1C(=O)N PYNBPZYZHMAOFS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2015/073563 WO2016138631A1 (fr) | 2015-03-03 | 2015-03-03 | Composés imidazo benzamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41641A true MA41641A (fr) | 2018-01-09 |
Family
ID=56849060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041641A MA41641A (fr) | 2015-03-03 | 2016-02-18 | Dérivés de tétrahydropyranylbenzamide |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US10196385B2 (fr) |
| EP (1) | EP3265460A4 (fr) |
| JP (1) | JP2018507232A (fr) |
| KR (1) | KR20170106483A (fr) |
| CN (1) | CN107406436B (fr) |
| AU (1) | AU2016228055B2 (fr) |
| BR (1) | BR112017015448A2 (fr) |
| CA (1) | CA2975413A1 (fr) |
| CL (1) | CL2017002148A1 (fr) |
| CO (1) | CO2017008721A2 (fr) |
| CR (1) | CR20170354A (fr) |
| DO (1) | DOP2017000196A (fr) |
| EA (1) | EA201791745A1 (fr) |
| EC (1) | ECSP17058071A (fr) |
| IL (1) | IL253405A0 (fr) |
| MA (1) | MA41641A (fr) |
| MX (1) | MX2017011087A (fr) |
| PE (1) | PE20171650A1 (fr) |
| PH (1) | PH12017501560A1 (fr) |
| SG (1) | SG11201706718RA (fr) |
| SV (1) | SV2017005520A (fr) |
| TN (1) | TN2017000372A1 (fr) |
| WO (2) | WO2016138631A1 (fr) |
| ZA (1) | ZA201704948B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018014337A1 (fr) * | 2016-07-22 | 2018-01-25 | Eli Lilly And Company | 3-chloro-n-[(1r18,3s)-3-[5-(3,5-diméthylimidazol-4-yl)-4h-1, 2, 4-triazol-3-yl]cyclohexyl]-n-méthyl-benzamide |
| US11261192B2 (en) | 2018-03-09 | 2022-03-01 | Recurium Ip Holdings, Llc | Substituted 1,2-dihydro-3H-pyrazolo[3,4-D]pyrimidin-3-ones |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010505957A (ja) | 2006-10-10 | 2010-02-25 | アムゲン インコーポレイティッド | 糖尿病に対して使用されるｎ−アリールピラゾール化合物 |
| US8188098B2 (en) | 2008-05-19 | 2012-05-29 | Hoffmann-La Roche Inc. | GPR119 receptor agonists |
| WO2010101247A1 (fr) * | 2009-03-05 | 2010-09-10 | 塩野義製薬株式会社 | Dérivé de cyclohexane présentant un antagonisme du récepteur npy y5 |
| JP2013517272A (ja) * | 2010-01-15 | 2013-05-16 | メルク・シャープ・エンド・ドーム・コーポレイション | 抗糖尿病化合物としてのオキサジアゾール・ベータ・カルボリン誘導体 |
| US8822471B2 (en) * | 2011-03-14 | 2014-09-02 | Boehringer Ingelheim International Gmbh | Compounds, pharmaceutical compositions and uses thereof |
| WO2015120610A1 (fr) | 2014-02-14 | 2015-08-20 | Eli Lilly And Company | Composé agoniste de gpr142 |
-
2015
- 2015-03-03 WO PCT/CN2015/073563 patent/WO2016138631A1/fr not_active Ceased
-
2016
- 2016-02-18 MA MA041641A patent/MA41641A/fr unknown
- 2016-02-19 CA CA2975413A patent/CA2975413A1/fr not_active Abandoned
- 2016-02-19 CR CR20170354A patent/CR20170354A/es unknown
- 2016-02-19 PE PE2017001456A patent/PE20171650A1/es not_active Application Discontinuation
- 2016-02-19 WO PCT/CN2016/074083 patent/WO2016138821A1/fr not_active Ceased
- 2016-02-19 CN CN201680013049.8A patent/CN107406436B/zh active Active
- 2016-02-19 US US15/118,295 patent/US10196385B2/en active Active
- 2016-02-19 EA EA201791745A patent/EA201791745A1/ru unknown
- 2016-02-19 SG SG11201706718RA patent/SG11201706718RA/en unknown
- 2016-02-19 EP EP16758437.4A patent/EP3265460A4/fr not_active Withdrawn
- 2016-02-19 TN TNP/2017/000372A patent/TN2017000372A1/en unknown
- 2016-02-19 MX MX2017011087A patent/MX2017011087A/es unknown
- 2016-02-19 KR KR1020177024303A patent/KR20170106483A/ko not_active Withdrawn
- 2016-02-19 BR BR112017015448A patent/BR112017015448A2/pt not_active IP Right Cessation
- 2016-02-19 AU AU2016228055A patent/AU2016228055B2/en not_active Expired - Fee Related
- 2016-02-19 JP JP2017546161A patent/JP2018507232A/ja active Pending
-
2017
- 2017-07-10 IL IL253405A patent/IL253405A0/en unknown
- 2017-07-20 ZA ZA2017/04948A patent/ZA201704948B/en unknown
- 2017-08-21 DO DO2017000196A patent/DOP2017000196A/es unknown
- 2017-08-22 SV SV2017005520A patent/SV2017005520A/es unknown
- 2017-08-23 CL CL2017002148A patent/CL2017002148A1/es unknown
- 2017-08-28 CO CONC2017/0008721A patent/CO2017008721A2/es unknown
- 2017-08-30 PH PH12017501560A patent/PH12017501560A1/en unknown
- 2017-09-01 EC ECIEPI201758071A patent/ECSP17058071A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2017002148A1 (es) | 2018-04-13 |
| ZA201704948B (en) | 2019-02-27 |
| BR112017015448A2 (pt) | 2018-01-30 |
| AU2016228055A1 (en) | 2017-08-17 |
| EP3265460A4 (fr) | 2018-08-08 |
| CO2017008721A2 (es) | 2018-01-05 |
| CR20170354A (es) | 2017-09-05 |
| CA2975413A1 (fr) | 2016-09-09 |
| IL253405A0 (en) | 2017-09-28 |
| US10196385B2 (en) | 2019-02-05 |
| CN107406436A (zh) | 2017-11-28 |
| US20180194755A1 (en) | 2018-07-12 |
| SV2017005520A (es) | 2018-08-27 |
| CN107406436B (zh) | 2021-02-26 |
| SG11201706718RA (en) | 2017-09-28 |
| MX2017011087A (es) | 2017-11-10 |
| DOP2017000196A (es) | 2017-09-15 |
| AU2016228055B2 (en) | 2018-06-07 |
| EP3265460A1 (fr) | 2018-01-10 |
| ECSP17058071A (es) | 2017-10-31 |
| WO2016138631A1 (fr) | 2016-09-09 |
| EA201791745A1 (ru) | 2018-01-31 |
| PH12017501560A1 (en) | 2018-02-05 |
| TN2017000372A1 (en) | 2019-01-16 |
| WO2016138821A1 (fr) | 2016-09-09 |
| PE20171650A1 (es) | 2017-11-13 |
| KR20170106483A (ko) | 2017-09-20 |
| JP2018507232A (ja) | 2018-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20230006I1 (fi) | Vutrisiraani | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| DK3642202T3 (da) | Dihydro-pyrrolo-pyridin-derivater | |
| EP3280487A4 (fr) | Estimation de distance électrode-nerf | |
| PT3157915T (pt) | Compostos de dihidroisoquinolinona substituídos | |
| PT3298027T (pt) | Compostos depsipéptidos antelmínticos | |
| EP3457851A4 (fr) | Dérivés de sobétirome | |
| MA39822A (fr) | Dérivés de pyrimidine bicycle | |
| MA54254A (fr) | Dérivés de benzodiazépine cytotoxique | |
| DK3253762T3 (da) | 9h-pyrrolo-dipyridinderivater. | |
| PT4039675T (pt) | Compostos de fenil-2-hidroxi-acetilamino-2-metil-fenilo | |
| LT3402792T (lt) | Chinolin-2-ono dariniai | |
| EP3334726A4 (fr) | Compositions de plinabuline | |
| LT3371168T (lt) | Indolin-2-ono dariniai | |
| EP3283171A4 (fr) | Dérivés d'amphotéricine b | |
| SMT202200173T1 (it) | Composti | |
| EP3430073A4 (fr) | Composition de polyaryléthercétone | |
| MA41790A (fr) | Dérivé de morphinane | |
| EP3309163A4 (fr) | Dérivé de dihydropyrrolopyrazole substitué | |
| LT3362444T (lt) | Junginiai | |
| PT3131898T (pt) | Derivados de fluoroalquilfluoreno | |
| CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
| DK3597189T3 (da) | Krystallinske forbindelser | |
| EP3333163A4 (fr) | Dérivé de guanidine substitué | |
| EP3308781A4 (fr) | Agent hypotenseur |